MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner

Arch Toxicol. 2014 Aug;88(8):1561-72. doi: 10.1007/s00204-014-1209-7. Epub 2014 Feb 13.

Abstract

Identification of the mechanisms by which drugs of abuse cause neuronal dysfunction is essential for understanding the biological bases of their acute and long-lasting effects in the brain. Here, we performed real-time functional experiments of axonal transport of mitochondria to explore the role of in situ mitochondrial dysfunction in 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")-related brain actions. We showed that MDMA dramatically reduced mitochondrial trafficking in hippocampal neurons in a Tau-dependent manner, in which glycogen synthase kinase 3β activity was implicated. Furthermore, we found that these trafficking abnormalities were rescued by over-expression of Mitofusin2 and dynamin-related protein 1, but not of Miro1. Given the relevance of mitochondrial targeting for neuronal function and neurotransmission, our data underscore a novel mechanism of action of MDMA that may contribute to our understanding of how this drug of abuse alters neuronal functioning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axonal Transport / drug effects
  • Calcium / metabolism
  • Cells, Cultured
  • Dynamins / metabolism*
  • GTP Phosphohydrolases / metabolism*
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / embryology
  • Mice, Inbred C57BL
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondrial Dynamics / drug effects*
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Phosphorylation
  • tau Proteins / metabolism*

Substances

  • Mapt protein, mouse
  • tau Proteins
  • GTP Phosphohydrolases
  • Mfn2 protein, mouse
  • Dnm1l protein, mouse
  • Dynamins
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Calcium